Table 3.
Clinical outcomes
| Varibales | uFSH (n = 764) |
rFSH-alfa (n = 314) |
P |
|---|---|---|---|
| CLBR | 329 (43.1%) | 168 (53.5%) | 0.002 |
| Time to first live birth (days) | 404.0 (357.0–496.0) | 392.0 (356.0–452.8) | 0.471 |
| Fresh embryo transfer, n | 201 (26.3%) | 110 (35.0%) | 0.005 |
| Pregnancy, n/N (%) | 68/201 (33.8%) | 36/110 (32.7%) | 0.844 |
| Abortion | 8/68 (11.8%) | 4/36 (11.1%) | 0.921 |
| Live birth | 54/201 (26.9%) | 28/110 (25.5%) | 0.787 |
| Multiple birth | 5/201 (2.5%) | 9/110 (8.2%) | 0.021 |
| Frozen embryo transfer cycles | 706 | 354 | |
| Pregnancy, n/N (%) | 344/706 (48.7%) | 169/354 (47.7%) | 0.762 |
| Abortion | 56/344 (16.3%) | 23/169 (13.6%) | 0.431 |
| Live birth | 276/706 (39.1%) | 142/354 (40.1%) | 0.749 |
| Multiple birth | 53/706 (7.5%) | 28/354 (7.9%) | 0.816 |
CLBR Cumulative live birth rate; FSH follicle-stimulating hormone